Detalles de la búsqueda
1.
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients.
Int J Cancer
; 154(8): 1371-1376, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100252
2.
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.
Int J Cancer
; 152(4): 661-671, 2023 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36056571
3.
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.
Int J Mol Sci
; 24(5)2023 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902406
4.
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
Breast Cancer Res
; 24(1): 71, 2022 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36307826
5.
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
Oncologist
; 27(9): e723-e730, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815922
6.
The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic.
Support Care Cancer
; 30(2): 1115-1125, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34432171
7.
Fight against cancer in Italy: What patients, caregivers and healthy citizens think about care delivery from National Health System.
Eur J Cancer Care (Engl)
; 31(6): e13763, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285464
8.
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients.
Pharmacogenomics J
; 21(4): 491-497, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649523
9.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
10.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943171
11.
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 22(1): 9, 2020 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31969184
12.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330065
13.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30536609
14.
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Breast Cancer Res
; 21(1): 133, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31796073
15.
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.
Breast Cancer Res Treat
; 163(3): 587-594, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28353061
16.
Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases.
J Bone Miner Metab
; 33(1): 119-24, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24553860
17.
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice.
Future Oncol
; 11(3): 431-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25675124
18.
Tumor shrinkage and improved quality of life in a heavily pretreated metastatic breast cancer patient treated with eribulin.
Future Oncol
; 9(11): 1703-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24156329
19.
Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.
Future Oncol
; 9(12): 1841-8, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295414
20.
Lung infiltrates in cancer patients: differentiating metastases from bronchiolitis obliterans organizing pneumonia.
Immunopharmacol Immunotoxicol
; 35(1): 195-7, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23098222